{
    "id": 1012,
    "fullName": "MET L1213V",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MET L1213V (corresponds to L1195V in the canonical isoform) lies within the protein kinase domain of the Met protein (UniProt.org). L1213V confers a gain of function to Met, resulting in constitutive Met phosphorylation and transformation of cultured cells (PMID: 15064724, PMID: 24061647).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 2196,
                    "pubMedId": 24061647,
                    "title": "The novel ATP-competitive inhibitor of the MET hepatocyte growth factor receptor EMD1214063 displays inhibitory activity against selected MET-mutated variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24061647"
                },
                {
                    "id": 452,
                    "pubMedId": 15064724,
                    "title": "The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15064724"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "L1213V",
    "createDate": "07/16/2014",
    "updateDate": "07/31/2019",
    "referenceTranscriptCoordinates": {
        "id": 144766,
        "transcript": "NM_001127500",
        "gDna": "chr7:g.116782048C>G",
        "cDna": "c.3637C>G",
        "protein": "p.L1213V",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 811,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a cell line expressing MET L1213V showed resistance to SU11274 treatment (PMID: 15064724).",
            "molecularProfile": {
                "id": 1121,
                "profileName": "MET L1213V"
            },
            "therapy": {
                "id": 1089,
                "therapyName": "SU11274",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 452,
                    "pubMedId": 15064724,
                    "title": "The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15064724"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1121,
            "profileName": "MET L1213V",
            "profileTreatmentApproaches": [
                {
                    "id": 7893,
                    "name": "MET Inhibitor",
                    "profileName": "MET L1213V"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144766,
            "transcript": "NM_001127500",
            "gDna": "chr7:g.116782048C>G",
            "cDna": "c.3637C>G",
            "protein": "p.L1213V",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}